Clarity Pharmaceuticals Ltd

A$1.50As of Sun 8 Nov 2026, 12:00 UTC
ASX:CU6Healthcare
Country Australia
PE (Fwd) •••
TSR 5Y CAGR 0.92%
Div yield —
ROE (77.54%)
Biotechnology
Beta (5Y) 1.17
PE TTM —
TSR TTM (69.49%)
Mkt cap A$557.8M
ROIC (49.02%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.45
(2.94%)
(94.75%)
Hold 11|1|11|9|8
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.03
0.03
0.03
0.03
24.59%
7.31%
(1.80%)
(7.60%)
Revenue$M
34.29
33.28
34.74
33.76
(2.18%)
(4.42%)
1.72%
(2.40%)
Peers (US$383.1M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.324
0.101
0.096
EBIT/Intx
1.365
0.115
0.125
Own earn%
(30.32)
37.88
35.84
Sh yield%
38.03
15.38
19.08
Owners
Insiders/Inst%
6.14
49.08
Short interest%
3.40
SBC / revenue%
5.90
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
5–13
$1 testx
0.0
Incr. ROIC%
5